Literature DB >> 25952461

Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6/2 mouse model of Huntington's disease.

Joshua W Callahan1, Elizabeth D Abercrombie1.   

Abstract

KEY POINTS: Neural synchrony between the subthalamic nucleus (STN) and cortex is critical for proper information processing in basal ganglia circuits. Using in vivo extracellular recordings in urethane-anaesthetized mice, we demonstrate that single units and local field potentials from the STN exhibit oscillatory entrainment to low-frequency (0.5-4 Hz) rhythms when the cortex is in a synchronized state. Here we report novel findings in the R6/2 transgenic mouse model of Huntington's disease (HD) by demonstrating that STN activity is reduced and less phase-locked to cortical low-frequency oscillations. The spectral power of low-frequency oscillations in ECoG recordings of R6/2 mice is diminished while the spectral power of higher frequencies is augmented and such altered cortical patterning could lead to decreased synchrony in corticosubthalamic circuits. Our data establish that cortical entrainment of STN neural activity is disrupted in R6/2 mice and may be one of the mechanisms contributing to disordered motor control in HD. ABSTRACT: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder in which impairments in the processing of information between the cortex and basal ganglia are fundamental to the onset and progression of the HD phenotype. The corticosubthalamic hyperdirect pathway plays a pivotal role in motor selection and blockade of neuronal activity in the subthalamic nucleus (STN) results in a hyperkinetic movement syndrome, similar to the HD phenotype. The aim of the present study was to examine the relationship between neuronal activity in the STN and cortex in an animal model of HD. We performed in vivo extracellular recordings in the STN to measure single-unit activity and local field potentials in the R6/2 transgenic mouse model of HD. These recordings were obtained during epochs of simultaneously acquired electrocorticogram (ECoG) in discrete brain states representative of global cortical network synchronization or desynchronization. Cortically patterned STN neuronal activity was less phase-locked in R6/2 mice, which is likely to result in less efficient coding of cortical inputs by the basal ganglia. In R6/2 mice, the power of the ECoG in lower frequencies (0.5-4 Hz) was diminished while the power expressed in higher frequencies (13-100 Hz) was increased. In addition, the spontaneous activity of STN neurons in R6/2 mice was reduced and neurons exhibited a more irregular firing pattern. Glutamatergic STN neurons provide the major excitatory drive to the output nuclei of the basal ganglia and altered discharge patterns could lead to aberrant basal ganglia output and disordered motor control in HD.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Year:  2015        PMID: 25952461      PMCID: PMC4560593          DOI: 10.1113/JP270268

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  64 in total

1.  Activity patterns in a model for the subthalamopallidal network of the basal ganglia.

Authors:  D Terman; J E Rubin; A C Yew; C J Wilson
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

2.  Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs.

Authors:  I Hamada; M R DeLong
Journal:  J Neurophysiol       Date:  1992-11       Impact factor: 2.714

3.  Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.

Authors:  Simon P Fisher; Sarah W Black; Michael D Schwartz; Alan J Wilk; Tsui-Ming Chen; Webster U Lincoln; Helen W Liu; Thomas S Kilduff; Stephen R Morairty
Journal:  Brain       Date:  2013-07       Impact factor: 13.501

4.  Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex.

Authors:  Nicolas Mallet; Alek Pogosyan; Andrew Sharott; Jozsef Csicsvari; J Paul Bolam; Peter Brown; Peter J Magill
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

5.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

6.  Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.

Authors:  Edward C Stack; James K Kubilus; Karen Smith; Kerry Cormier; Steven J Del Signore; Emmanuel Guelin; Hoon Ryu; Steven M Hersch; Robert J Ferrante
Journal:  J Comp Neurol       Date:  2005-10-03       Impact factor: 3.215

Review 7.  Neural mechanisms in disorders of movement.

Authors:  A R Crossman
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1989

8.  Chronux: a platform for analyzing neural signals.

Authors:  Hemant Bokil; Peter Andrews; Jayant E Kulkarni; Samar Mehta; Partha P Mitra
Journal:  J Neurosci Methods       Date:  2010-07-15       Impact factor: 2.390

9.  Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease.

Authors:  V W S Kung; R Hassam; A J Morton; S Jones
Journal:  Neuroscience       Date:  2007-05-02       Impact factor: 3.590

10.  Cortical and brainstem LTP-like plasticity in Huntington's disease.

Authors:  Domenica Crupi; Maria Felice Ghilardi; Clara Mosiello; Alessandro Di Rocco; Angelo Quartarone; Fortunato Battaglia
Journal:  Brain Res Bull       Date:  2007-08-22       Impact factor: 4.077

View more
  11 in total

1.  Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.

Authors:  Ana María Estrada-Sánchez; Courtney L Blake; Scott J Barton; Andrew G Howe; George V Rebec
Journal:  J Neurophysiol       Date:  2019-11-06       Impact factor: 2.714

2.  Dysregulation of the Basal Ganglia Indirect Pathway in Early Symptomatic Q175 Huntington's Disease Mice.

Authors:  Joshua W Callahan; David L Wokosin; Mark D Bevan
Journal:  J Neurosci       Date:  2022-01-20       Impact factor: 6.709

3.  Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease.

Authors:  Jeremy F Atherton; Eileen L McIver; Matthew Rm Mullen; David L Wokosin; D James Surmeier; Mark D Bevan
Journal:  Elife       Date:  2016-12-20       Impact factor: 8.140

4.  Chronic Paroxetine Treatment Prevents the Emergence of Abnormal Electroencephalogram Oscillations in Huntington's Disease Mice.

Authors:  Sandor Kantor; Janos Varga; Shreya Kulkarni; A Jennifer Morton
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 5.  Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development?

Authors:  Michael K Leuchter; Elissa J Donzis; Carlos Cepeda; Aimee M Hunter; Ana María Estrada-Sánchez; Ian A Cook; Michael S Levine; Andrew F Leuchter
Journal:  Front Neurol       Date:  2017-03-30       Impact factor: 4.003

6.  Reward Based Motor Adaptation Mediated by Basal Ganglia.

Authors:  Taegyo Kim; Khaldoun C Hamade; Dmitry Todorov; William H Barnett; Robert A Capps; Elizaveta M Latash; Sergey N Markin; Ilya A Rybak; Yaroslav I Molkov
Journal:  Front Comput Neurosci       Date:  2017-03-31       Impact factor: 2.380

7.  EEG Functional Connectivity and Cognitive Variables in Premanifest and Manifest Huntington's Disease: EEG Low-Resolution Brain Electromagnetic Tomography (LORETA) Study.

Authors:  Marianna Delussi; Virgilio Nazzaro; Katia Ricci; Marina de Tommaso
Journal:  Front Physiol       Date:  2020-12-17       Impact factor: 4.566

Review 8.  Multi-scale neural decoding and analysis.

Authors:  Hung-Yun Lu; Elizabeth S Lorenc; Hanlin Zhu; Justin Kilmarx; James Sulzer; Chong Xie; Philippe N Tobler; Andrew J Watrous; Amy L Orsborn; Jarrod Lewis-Peacock; Samantha R Santacruz
Journal:  J Neural Eng       Date:  2021-08-16       Impact factor: 5.043

9.  Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.

Authors:  Yunping Deng; Hongbing Wang; Marion Joni; Radhika Sekhri; Anton Reiner
Journal:  J Comp Neurol       Date:  2020-09-20       Impact factor: 3.215

10.  Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease.

Authors:  Justin L Shobe; Elissa J Donzis; Kwang Lee; Samiksha Chopra; Sotiris C Masmanidis; Carlos Cepeda; Michael S Levine
Journal:  Neurobiol Dis       Date:  2021-07-16       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.